Growth Metrics

ENvue Medical (FEED) Long-Term Deferred Tax (2024 - 2025)

ENvue Medical (FEED) reported Long-Term Deferred Tax of $13.9 million for Q4 2025, up 36.25% year-over-year from $10.2 million in Q4 2024, and up 36.25% on a QoQ basis from $10.2 million in Q4 2024.

ENvue Medical (FEED) has 2 years of Long-Term Deferred Tax data on file, last reported at $13.9 million in Q4 2025.

  • Quarterly Long-Term Deferred Tax rose 36.25% year-over-year to $13.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $13.9 million (up 36.25% YoY) and the FY2025 annual result came in at $13.9 million, up 36.25% from the prior year.
  • Long-Term Deferred Tax grew to $13.9 million in Q4 2025 per FEED's latest filing, from $10.2 million in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $13.9 million in Q4 2025 and bottomed at $10.2 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 ENvue Medical 2.97 Mn 709,615.89 -55,000.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 13.94 Mn
Dec 31, 2024 24,000.00